Lixte Biotechnology Holdings Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.2% | -1.1% | +27.0% | -18.3% | -27.0% | +27.9% | +168.7% | +206.5% | -54.8% | -77.8% | +757.2% | – | |
| – | – | +203.6% | -22.7% | -228.1% | – | – | -51.2% | +144.9% | +510.7% | -133.7% | – | – | |
| – | – | -100.0% | – | – | -100.0% | – | +66.7% | -60.0% | +50.0% | +828,466.7% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | -79.7% | -95.4% | +26,047.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -97.4% | +0.0% | – | |
| – | -100.0% | – | – | – | – | – | -101.1% | – | -31.0% | -100.0% | – | – | |
| – | -141.1% | – | – | – | – | – | -243.9% | – | +10.9% | -183.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.